Suboptimal adherence to once-daily antihypertensives, tracked via electronic dosing histories, is a major driver of poor blood pressure control.
Adherence shortfalls may underlie poor hypertension control in practice; leaves open whether targeted interventions improve outcomes.
Early discontinuation of treatment and suboptimal daily execution of the prescribed regimens are the most common facets of poor adherence with once a day antihypertensive drug treatments. The shortfalls in drug exposure that these dosing errors create might be a common cause of low rates of blood pressure control and high variability in responses to prescribed antihypertensive drugs.
No takes yet. Share an insight, caveat, or question.
Vrijens et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: